Back to Search Start Over

Outcome after extracorporeal membrane oxygenation-bridged lung retransplants: a single-centre experience.

Authors :
Abdelnour-Berchtold E
Federici S
Wurlod DA
Bellier J
Zellweger M
Kirsch M
Nicod L
Marcucci C
Baeriswyl M
Liaudet L
Soccal PM
Gonzalez M
Perentes JY
Ris HB
Krueger T
Aubert JD
Source :
Interactive cardiovascular and thoracic surgery [Interact Cardiovasc Thorac Surg] 2019 Jun 01; Vol. 28 (6), pp. 922-928.
Publication Year :
2019

Abstract

Objectives: A lung retransplant has been shown to be a valid option in selected patients with chronic lung allograft dysfunction (CLAD). However, a subgroup of patients may require, in addition to invasive mechanical ventilation, extracorporeal membrane oxygenation (ECMO) as a bridge to a retransplant. Overall and CLAD-free survival after ECMO-bridged retransplants are compared to first transplants with and without bridging ECMO and to retransplants without bridging ECMO.<br />Methods: We reported a retrospective, single-institution experience based on a prospective data set of all patients undergoing lung transplants between January 2004 and December 2016 with a mean follow-up of 51 ± 41 months.<br />Results: A total of 230 patients (96 men, 134 women, mean age 47.3 years) had lung transplants: 200 had first transplants without bridging ECMO; 13 had first transplants with bridging ECMO; 11 had retransplants without bridging ECMO; and 6 had retransplants with bridging ECMO. The 3- and 5-year survival rates were 81%/76%, 68%/68%, 69%/46% and 50%/25%, respectively. There was no significant difference in overall survival between those who had first transplants with and without bridging ECMO or retransplants without bridging ECMO. In contrast, patients undergoing ECMO-bridged retransplants had a significantly lower overall survival rate than those with a first transplant without bridging ECMO (P = 0.007). In addition, the post-transplant CLAD-free survival curves varied significantly among the 4 treatment groups (P = 0.041), paralleling overall survival.<br />Conclusions: Patients requiring ECMO as a bridge to a retransplant had lower overall and CLAD-free survival rates compared to those who had a first transplant with and without bridging ECMO and a retransplant without bridging ECMO.<br /> (© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)

Details

Language :
English
ISSN :
1569-9285
Volume :
28
Issue :
6
Database :
MEDLINE
Journal :
Interactive cardiovascular and thoracic surgery
Publication Type :
Academic Journal
Accession number :
30726919
Full Text :
https://doi.org/10.1093/icvts/ivz013